基本信息
浏览量:5
职业迁徙
个人简介
Tom Williams joined the Department of Medicine at Imperial College as Professor of Haemoglobinopathy Research in April 2013. Based in Oxford for much of the previous 20 years, his appointment marks a return to Imperial College, having qualified in Medicine from Westminster Medical School and conducted much of his clinical training in London hospitals.
Professor Williams has been a Wellcome Trust Senior Fellow in Clinical Science since 2005. His research base is the KEMRI-Wellcome Trust Collaborative Programme in Kilifi, Kenya although his work involves extensive collaborations with colleagues throughout Africa, most notably with Dr Peter Olupot Olupot at the Mbale Clinical Research Institute (MCRI) in Eastern Uganda and with colleagues within the REACH consortium of clinical trial sites for sickle cell disease across the continent.
Tom's research group works on the positive and negative health consequences of a range of genetic disorders, with a particular focus on disorders affecting the red blood cell. They address this question through a range of approaches including large-scale epidemiological studies, health-economic studies, clinical trials, and laboratory-based studies that focus on the mechanisms of malaria resistance in children with defined red cell disorders. Examples of current projects include: a birth cohort study of more than 16,000 children, genotyped for a range of genetic polymorphisms, who are being followed for clinical events in Kilifi District, Kenya; descriptive studies of the natural history of sickle cell disease in East Africa; studies of the nutritional consequences of a range of red cell disorders and clinical trials in sick children, including two trials of hydroxyurea as a potential therapy in African children with sickle cell disease (REACH and H-PRIME).
Professor Williams has been a Wellcome Trust Senior Fellow in Clinical Science since 2005. His research base is the KEMRI-Wellcome Trust Collaborative Programme in Kilifi, Kenya although his work involves extensive collaborations with colleagues throughout Africa, most notably with Dr Peter Olupot Olupot at the Mbale Clinical Research Institute (MCRI) in Eastern Uganda and with colleagues within the REACH consortium of clinical trial sites for sickle cell disease across the continent.
Tom's research group works on the positive and negative health consequences of a range of genetic disorders, with a particular focus on disorders affecting the red blood cell. They address this question through a range of approaches including large-scale epidemiological studies, health-economic studies, clinical trials, and laboratory-based studies that focus on the mechanisms of malaria resistance in children with defined red cell disorders. Examples of current projects include: a birth cohort study of more than 16,000 children, genotyped for a range of genetic polymorphisms, who are being followed for clinical events in Kilifi District, Kenya; descriptive studies of the natural history of sickle cell disease in East Africa; studies of the nutritional consequences of a range of red cell disorders and clinical trials in sick children, including two trials of hydroxyurea as a potential therapy in African children with sickle cell disease (REACH and H-PRIME).
研究兴趣
论文共 35 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Bloodno. 12 (2022): 1402-1410
S. Uyoga,J. A. Watson, P. Wanjiku, J. C. Rop, J. Makale, A. W. Macharia,S. N. Kariuki, G. M. Nyutu, M. Shebe, M. Mosobo, N. Mturi, K. A. Rockett,
J. Gilchrist,S. N. Kariuki,J. A. Watson, G. Band,S. Uyoga, C. M. Ndila, N. Mturi, S. Mwarumba, S. Mohammed, M. Mosobo, K. Rockett,A. Mentzer,
Wellcome open research (2022): 188-188
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn